-
公开(公告)号:US08399464B2
公开(公告)日:2013-03-19
申请号:US11885575
申请日:2006-03-08
申请人: Hiroshi Kuramochi , Setsuko Niitsuma , Masaharu Nakamura , Yoshitaka Sato , Seiichi Saito , Arihiro Tomura , Yuh-ichiro Ichikawa , Yousuke Kasuga
发明人: Hiroshi Kuramochi , Setsuko Niitsuma , Masaharu Nakamura , Yoshitaka Sato , Seiichi Saito , Arihiro Tomura , Yuh-ichiro Ichikawa , Yousuke Kasuga
IPC分类号: A61K31/535
CPC分类号: C07D249/12 , C07D249/14 , C07D401/12 , C07D403/12 , C07D405/12
摘要: Disclosed is a triazole derivative(s) represented by the general formula (1) below or a pharmacologically acceptable salt(s) thereof. Also disclosed are a prodrug(s) of such a triazole derivative(s) and an HSP90 inhibitor(s) containing any one of them as an active constituent. (1) (In the formula, X represents a halogen atom, an optionally substituted alkyl group, an optionally substituted alkynyl group or the like; Y represents a mercapto group, a hydroxyl group, an optionally substituted sulfonyl group, an optionally substituted amino group or the like; and R represents an optionally substituted aryl or alkyl group or the like.)
摘要翻译: 公开了由以下通式(1)表示的三唑衍生物或其药理学上可接受的盐。 还公开了这样的三唑衍生物的前药和含有它们中任何一种作为活性成分的HSP90抑制剂。 (1)(式中,X表示卤素原子,可以具有取代基的烷基,可以具有取代基的炔基等; Y表示巯基,羟基,可以具有取代基的磺酰基,可以具有取代基的氨基 或类似物; R代表任选取代的芳基或烷基等)。
-
公开(公告)号:US20080269218A1
公开(公告)日:2008-10-30
申请号:US11885575
申请日:2006-03-08
申请人: Hiroshi Kuramochi , Setsuko Niitsuma , Masaharu Nakamura , Yoshitaka Sato , Seiichi Saito , Arihiro Tomura , Yuh-Ichiro Ichikawa , Yousuke Kasuga
发明人: Hiroshi Kuramochi , Setsuko Niitsuma , Masaharu Nakamura , Yoshitaka Sato , Seiichi Saito , Arihiro Tomura , Yuh-Ichiro Ichikawa , Yousuke Kasuga
IPC分类号: A61K31/5377 , C07D413/02 , A61K31/454 , A61K31/4196 , C07D249/12 , A61P35/00
CPC分类号: C07D249/12 , C07D249/14 , C07D401/12 , C07D403/12 , C07D405/12
摘要: Disclosed is a triazole derivative represented by the general formula (1) below or a pharmacologically acceptable salt thereof. Also disclosed are a prodrug of such a triazole derivative and an HSP90 inhibitor containing any one of them as an active constituent. (1) (In the formula, X represents a halogen atom, an optionally substituted alkyl group, an optionally substituted alkenyl group or the like; Y represents a mercapto group, a hydroxyl group, an optionally substituted sulfonyl group, an optionally substituted amino group or the like; and R represents an optionally substituted aryl or amino group or the like.)
摘要翻译: 公开了由下述通式(1)表示的三唑衍生物或其药理学上可接受的盐。 还公开了这种三唑衍生物的前体药物和含有它们中任何一种作为活性成分的HSP90抑制剂。 (1)(式中,X表示卤原子,可以具有取代基的烷基,可以具有取代基的烯基等; Y表示巯基,羟基,可以具有取代基的磺酰基,可以具有取代基的氨基 或类似物; R代表任选取代的芳基或氨基等)。
-